Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free AUTL Stock Alerts

Autolus Therapeutics (AUTL) Short Interest Ratio & Short Volume

Autolus Therapeutics logo
$1.62 -0.13 (-7.43%)
Closing price 04:00 PM Eastern
Extended Trading
$1.68 +0.06 (+3.70%)
As of 06:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Autolus Therapeutics Short Interest Overview

As of May 15, 2026, Autolus Therapeutics (AUTL) had a short interest of 14.02 million shares sold short, representing 7.09% of the public float. This marks a 7.10% increase in short interest since the prior report. The short interest ratio (days to cover) is 8.6, meaning it would take 8.6 days of the average trading volume of 1.75 million shares to cover all short positions.

Current Short Interest
14,017,528 shares
Previous Short Interest
13,088,539 shares
Change Vs. Previous Month
7.10%
Dollar Volume Sold Short
$22.85 million
Short Interest Ratio
8.6 Days to Cover
Last Record Date
May 15, 2026
Outstanding Shares
266,140,000 shares
Short Percent of Float
7.09%
Today's Trading Volume
2,057,815 shares
Average Trading Volume
1,752,447 shares
Today's Volume Vs. Average
117%
Short Selling Autolus Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Autolus Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AUTL Short Interest Over Time

AUTL Days to Cover Over Time

AUTL Percentage of Float Shorted Over Time

Autolus Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202614,017,528 shares $22.85 million +7.1%7.1%8.62 $1.63
4/30/202613,088,539 shares $18.45 million -7.9%6.6%10.52 $1.41
4/15/202614,206,924 shares $21.17 million -2.6%7.2%10.38 $1.49
3/31/202614,582,459 shares $20.12 million -0.8%7.4%7.18 $1.38
3/13/202614,696,007 shares $21.16 million -1.8%7.4%9.7 $1.44
2/27/202614,966,126 shares $25.59 million -5.6%7.6%8.77 $1.71
2/13/202615,860,958 shares $22.21 million +2.8%8.0%13.78 $1.40
1/30/202615,435,023 shares $21.15 million +11.0%7.8%9.02 $1.37
1/15/202613,902,770 shares $20.02 million +13.1%7.0%4.74 $1.44
12/31/202512,295,794 shares $24.47 million +1.4%6.2%4.82 $1.99
12/15/202512,128,428 shares $19.65 million -6.3%6.1%4.51 $1.62
11/28/202512,948,282 shares $18.26 million +11.0%6.5%2.59 $1.41
11/14/202511,662,315 shares $15.98 million -2.7%5.9%4.44 $1.37
10/31/202511,981,268 shares $18.57 million +1.4%6.1%5.4 $1.55
10/15/202511,820,000 shares $20.33 million +2.9%6.0%3.3 $1.72
9/30/202511,490,000 shares $18.73 million +8.3%N/A3.3 $1.63
9/15/202510,610,000 shares $14.01 million +5.0%N/A3.5 $1.32
8/31/202510,110,000 shares $15.17 million -32.2%5.1%3.9 $1.50
8/15/202514,900,000 shares $26.52 million +5.4%N/A6.7 $1.78
7/31/202514,140,000 shares $33.94 million +3.5%7.2%6.8 $2.40
7/15/202513,660,000 shares $34.01 million -0.1%N/A6.3 $2.49
6/30/202513,670,000 shares $31.17 million +7.6%6.9%6 $2.28
6/15/202512,710,000 shares $26.95 million +9.9%6.4%5.6 $2.12
5/31/202511,570,000 shares $20.13 million +9.3%5.9%5.4 $1.74
5/15/202510,590,000 shares $13.66 million +1.3%5.4%5.5 $1.29
4/30/202510,450,000 shares $14.73 million -8.7%N/A5.9 $1.41
4/15/202511,450,000 shares $16.03 million +15.5%5.8%7.3 $1.40
3/31/20259,910,000 shares $15.36 million +8.5%5.0%7.3 $1.55
3/15/20259,130,000 shares $17.07 million +0.3%4.6%7 $1.87
2/28/20259,100,000 shares $15.74 million -4.1%4.6%6.5 $1.73
2/15/20259,490,000 shares $19.36 million +4.2%4.8%6.5 $2.04
1/31/20259,110,000 shares $20.13 million +8.7%N/A5.3 $2.21
1/15/20258,380,000 shares $19.53 million -2.9%N/A4.6 $2.33
12/31/20248,630,000 shares $20.28 million +12.4%N/A4.7 $2.35
12/15/20247,680,000 shares $19.12 million +22.1%N/A4.4 $2.49
11/30/20246,290,000 shares $20.88 million +0.6%N/A4.1 $3.32
11/15/20246,250,000 shares $19.25 million -13.1%N/A4.4 $3.08
10/31/20247,190,000 shares $24.23 million -17.8%N/A6.4 $3.37
10/15/20248,750,000 shares $37.28 million -13.3%N/A10.9 $4.26
9/30/202410,090,000 shares $36.63 million -6.0%N/A11.5 $3.63
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
9/15/202410,730,000 shares $43.78 million -6.1%N/A11.1 $4.08
8/31/202411,430,000 shares $44.92 million -8.0%N/A10.4 $3.93
8/15/202412,420,000 shares $46.58 million No ChangeN/A10.3 $3.75
7/31/202412,420,000 shares $58.25 million +4.4%N/A9.3 $4.69
7/15/202411,900,000 shares $52.96 million +74.7%N/A7 $4.45
6/30/20246,810,000 shares $23.70 million +5.9%N/A4.2 $3.48
6/15/20246,430,000 shares $28.94 million +79.1%N/A4.1 $4.50
5/31/20243,590,000 shares $15.04 million +10.5%N/A2.4 $4.19
5/15/20243,250,000 shares $12.77 million -7.7%N/A2.1 $3.93
4/30/20243,520,000 shares $12.95 million -13.5%N/A1.9 $3.68
4/15/20244,070,000 shares $19.94 million -2.4%N/A2.6 $4.90
3/31/20244,170,000 shares $26.60 million +32.4%N/A2.6 $6.38
3/15/20243,150,000 shares $18.33 million +13.7%N/A1.9 $5.82
2/29/20242,770,000 shares $16.62 million -10.7%N/A1.7 $6.00
2/15/20243,100,000 shares $21.95 million +5.4%N/A1.9 $7.08
1/31/20242,940,000 shares $17.70 million +21.5%N/A2.1 $6.02
1/15/20242,420,000 shares $17.40 million +12.0%N/A2.1 $7.19
12/31/20232,160,000 shares $13.91 million -18.5%N/A2.2 $6.44
12/15/20232,650,000 shares $13.28 million +26.8%N/A3.2 $5.01
11/30/20232,090,000 shares $8.95 million +41.2%N/A3.3 $4.28
11/15/20231,480,000 shares $6.28 million +0.7%N/A2.8 $4.24
10/31/20231,470,000 shares $4.15 million -2.0%N/A3.7 $2.82
10/15/20231,500,000 shares $3.53 million +5.6%N/A4.2 $2.35
9/30/20231,420,000 shares $3.31 million -11.8%N/A3.8 $2.33
9/15/20231,610,000 shares $4.62 million +17.5%N/A3.6 $2.87
8/31/20231,370,000 shares $4.40 million -16.5%N/A3 $3.21
8/15/20231,640,000 shares $4.51 million -12.3%N/A2.7 $2.75
7/31/20231,870,000 shares $6.04 million +18.4%N/A2.6 $3.23
7/15/20231,580,000 shares $3.89 million +6.0%N/A2.2 $2.46
6/30/20231,490,000 shares $3.55 million +4.9%N/A2.2 $2.38
6/15/20231,420,000 shares $4.02 million -11.8%N/A2.1 $2.83
5/31/20231,610,000 shares $5.01 million +117.7%N/A2.3 $3.11
5/15/2023739,700 shares $1.86 million -14.1%N/A1.3 $2.52
4/30/2023861,000 shares $1.56 million -33.3%N/A1.6 $1.81
4/15/20231,290,000 shares $2.32 million -24.1%N/A2.5 $1.80
3/31/20231,700,000 shares $3.13 million +40.5%N/A3.1 $1.84
3/15/20231,210,000 shares $2.53 million +7.1%N/A2.2 $2.09
2/28/20231,130,000 shares $2.19 million -10.3%N/A1.5 $1.94
2/15/20231,260,000 shares $2.42 million +43.6%N/A1.7 $1.92
1/31/2023877,400 shares $1.89 million +75.3%N/A1.3 $2.15
1/15/2023500,400 shares $1.05 million -24.3%N/A0.9 $2.10
12/30/2022661,000 shares $1.26 million +42.4%N/A1.2 $1.90
12/15/2022464,200 shares $858.77 thousand -45.8%N/A1 $1.85
11/30/2022856,700 shares $2.26 million -19.2%N/A4.7 $2.64
11/15/20221,060,000 shares $2.12 million +16.9%N/A6.7 $2.00
10/31/2022906,900 shares $2.58 million -9.3%N/A5.8 $2.85
10/15/20221,000,000 shares $3.25 million -3.9%N/A6.4 $3.25
9/30/20221,040,000 shares $2.23 million -3.7%N/A7.7 $2.14
9/15/20221,080,000 shares $2.98 million -4.4%N/A8.4 $2.76
8/31/20221,130,000 shares $3.73 million -3.4%N/A8.1 $3.30
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

See the 5 stocks to avoid
8/15/20221,170,000 shares $4.40 million -10.7%N/A8 $3.76
7/31/20221,310,000 shares $3.65 million -7.8%N/A7.8 $2.79
7/15/20221,420,000 shares $4.08 million -11.8%N/A8 $2.87
6/30/20221,610,000 shares $4.56 million -5.3%N/A7.7 $2.83
6/15/20221,700,000 shares $3.47 million -16.3%N/A7.8 $2.04
5/31/20222,030,000 shares $5.56 million -1.5%N/A8.7 $2.74
5/15/20222,060,000 shares $4.88 million -4.2%N/A7.4 $2.37
4/30/20222,150,000 shares $6.71 million -0.5%N/A7.1 $3.12
4/15/20222,160,000 shares $8.73 million -13.9%N/A6.2 $4.04
3/31/20222,510,000 shares $10.47 million -13.8%4.0%6.8 $4.17
3/15/20222,910,000 shares $11.38 million -5.2%4.6%6.7 $3.91
2/28/20223,070,000 shares $11.48 million -0.3%6.1%5.9 $3.74
2/15/20223,080,000 shares $14.01 million +2.3%6.1%5.8 $4.55
1/31/20223,010,000 shares $12.01 million +10.7%N/A2.4 $3.99
1/15/20222,720,000 shares $12.00 million -0.7%N/A2.2 $4.41
12/31/20212,740,000 shares $14.22 million +18.1%N/A2.3 $5.19
12/15/20212,320,000 shares $13.08 million +12.6%N/A2 $5.64
11/30/20212,060,000 shares $13.25 million -17.6%N/A1.9 $6.43
11/15/20212,500,000 shares $16.98 million +39.7%N/A2.3 $6.79
10/29/20211,790,000 shares $9.99 million +3.5%N/A1.6 $5.58
10/15/20211,730,000 shares $10.62 million -12.2%N/A2.1 $6.14
9/30/20211,970,000 shares $12.90 million +4.2%N/A2 $6.55
9/15/20211,890,000 shares $12.47 million -21.6%N/A1.6 $6.60
8/31/20212,410,000 shares $16.56 million -14.2%N/A1.5 $6.87
8/13/20212,810,000 shares $16.61 million +30.1%N/A1.6 $5.91
7/30/20212,160,000 shares $11.49 million +10.2%N/A1 $5.32
7/15/20211,960,000 shares $11.52 million -2.0%N/A1.1 $5.88
6/30/20212,000,000 shares $13.28 million -11.9%N/A1.2 $6.64
6/15/20212,270,000 shares $17.32 million +1.8%N/A1.5 $7.63

AUTL Short Interest - Frequently Asked Questions

Short interest is the volume of Autolus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 14,017,528 shares of AUTL short. 7.09% of Autolus Therapeutics' shares are currently sold short. Learn More on Autolus Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AUTL shares currently have a short interest ratio of 8.6. Learn More on Autolus Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.09% of Autolus Therapeutics' floating shares are currently sold short.

Autolus Therapeutics saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 14,017,528 shares, an increase of 7.1% from the previous total of 13,088,539 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

7.09% of Autolus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Autolus Therapeutics: Nurix Therapeutics, Inc. (19.31%), Rapport Therapeutics, Inc. (5.85%), Ocular Therapeutix, Inc. (11.58%), Sarepta Therapeutics, Inc. (25.45%), Vericel Corporation (11.31%), Syndax Pharmaceuticals, Inc. (25.55%), Intellia Therapeutics, Inc. (38.30%), Harmony Biosciences Holdings, Inc. (12.84%), AnaptysBio, Inc. (24.78%), Oculis Holding AG (0.86%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($80.71 billion), Invesco QQQ ($47.96 billion), iShares Russell 2000 ETF ($22.13 billion), Western Digital Corporation ($14.35 billion), Sandisk Corporation ($12.86 billion), Salesforce Inc. ($10.89 billion), Nebius Group N.V. ($9.92 billion), SPDR S&P Biotech ETF ($9.72 billion), Lumentum Holdings Inc. ($8.89 billion), and iShares 20+ Year Treasury Bond ETF ($8.18 billion). View all of the most shorted stocks.

Short selling AUTL is an investing strategy that aims to generate trading profit from Autolus Therapeutics as its price is falling. AUTL shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Autolus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AUTL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AUTL, twice per month. The most recent reporting period available is May, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AUTL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:AUTL) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel